Arrowhead Pharmaceuticals, Inc. today announced interim results from a Phase 1/2a clinical study of ARO-CFB, the company's investigational RNA interference (RNAi) therapeutic targeting complement ...

PAR Technology , a global foodservice technology company, today announces that Condado Tacos, the rapidly growing restaurant brand celebrated for its custom tacos and bold flavors, has selected PAR® ...

Arrowhead (ARWR) announced interim results from a Phase 1/2a clinical study of ARO-CFB, the company’s investigational RNA interference, or ...

We’ll also explore the company’s innovative approach to treating cancer, particularly those driven by KRAS mutations, and why Prof. Peled’s addition could be a game-changer. The recent appointment of ...

The drug discovery specialist is laying off staff in a pivot that could take it private. Elsewhere, AbbVie reported a second Parkinson’s study success and Biogen hired a new Wall Street whisperer.

Researchers at the University of Ottawa have figured out how to use mRNA and RNAI-based treatments to treat complex illnesses ...

CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA-targeting therapeutics designed to upregulate gene expression with the ...

Prof. Peled, a globally recognized scientific authority who has been involved in multiple successful publicly traded ...

The oligonucleotides market has gained significant traction in recent years due to its critical role in molecular biology, genetics, and therapeutics. Oligonucleotides, short DNA or RNA molecules, are ...

Researchers at the University of Ottawa may have cracked the code to harness both mRNA and RNAI-based therapies to improve ...

Researchers have recently revealed new insights into how brittle stars can reversibly adjust the pliability of their tissues.

One of their distinctive abilities is detaching a portion of the body to escape from predators. A few species of brittle ...